Published • loading... • Updated
VERAXA Biotech Expands Human-Relevant Testing to Advance BiTAC Cancer Therapies
Summary by citybuzz.co
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
VERAXA Biotech Expands Human-Relevant Testing to Advance BiTAC Cancer Therapies
VERAXA Biotech is expanding its use of human-relevant preclinical testing methods to improve the clinical relevance of its antibody-based cancer drug development while reducing animal testing. The post VERAXA Biotech Expands Human-Relevant Testing to Advance BiTAC Cancer Therapies appeared first on citybuzz.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
